test

Nnamdi Etoh

@Rock Springs Capital Management Lp

Latest period2024 - Q3ReportedManaged Assets$3.074BTotal holdings109
Assets growth rate-7.48%Assets growth rate (2-Q avg)-11.56%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Rock Springs Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 109 positions.

Assets under management

The assets under management (AUM) of Rock Springs Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.074B in assets, with a quarterly growth rate of -7.48% and a 2-quarter average growth rate of -11.56%. The portfolio is managed by Nnamdi Etoh, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
UNHUnitedhealth Group Inc
Recent Activity
Increased 7.01%
5.6%
$172.042M
294,250 shares@ $584.68 avg price
ISRGIntuitive Surgical Inc
Recent Activity
Decreased -9.54%
4.32%
$132.643M
270,000 shares@ $491.27 avg price
ARGXArgenx Se
Recent Activity
Increased 1.86%
4.12%
$126.576M
233,500 shares@ $542.08 avg price
LLYEli Lilly & Co
Recent Activity
Increased 16.88%
4.1%
$125.803M
142,000 shares@ $885.94 avg price
RAREUltragenyx Pharmaceutical In
Recent Activity
Increased 2.82%
3.58%
$109.893M
1.978M shares@ $55.56 avg price
NBIXNeurocrine Biosciences Inc
Recent Activity
Decreased -0.1%
3.52%
$108.192M
939,000 shares@ $115.22 avg price
EXASExact Sciences Corp
Recent Activity
Increased 6.11%
2.55%
$78.168M
1.147M shares@ $68.12 avg price
BPMCBlueprint Medicines Corp
Recent Activity
Decreased -69.46%
2.32%
$71.112M
768,776 shares@ $92.5 avg price
ALNYAlnylam Pharmaceuticals Inc
Recent Activity
2.24%
$68.758M
250,000 shares@ $275.03 avg price
TVTXTravere Therapeutics Inc
Recent Activity
Increased 4.52%
2.14%
$65.536M
4.684M shares@ $13.99 avg price